Reports from conference proceedings suggest that KB407 possesses a robust safety and efficacy profile in multiple in vitro CF models including functional restoration of CFTR in clinically relevant patient-derived intestinal organoids cultured from four CF patients65,67. Here, CFTR is linked to cystic fibrosis.